Windlas Biotech Ltd Half Yearly Results

Gross Sales

432.49

397.72

362.15

333.5

297.46

Excise Duty

0

0

0

0

0

Net Sales

432.49

397.72

362.15

333.5

297.46

Other Operating Income

0

0

0

0

0

Other Income

8.88

9.04

8.97

7.6

5.86

Total Income

441.37

406.77

371.13

341.1

303.32

Total Expenditure

377.41

347.55

318.23

291.16

261.63

PBIDT

63.96

59.22

52.9

49.95

41.69

Interest

2.07

2.79

1.6

0.58

0.52

PBDT

61.89

56.44

51.31

49.36

41.17

Depreciation

15.05

15.27

12.71

6.93

6.52

Minority Interest Before NP

0

0

0

0

0

Tax

11.43

8.55

9.74

9.02

8.35

Deferred Tax

-0.05

0.76

-0.28

1.33

0.2

Reported Profit After Tax

35.46

31.86

29.14

32.09

26.1

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

35.46

31.86

29.14

32.09

26.1

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

35.46

31.86

29.14

32.09

26.1

EPS (Unit Curr.)

16.91

15.2

13.97

15.43

12.54

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

10.45

10.48

10.45

10.4

10.4

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

14.78

14.88

14.6

14.97

14.01

PBDTM(%)

-

-

-

-

-

PATM(%)

8.19

8.01

8.04

9.62

8.77